| How DNA microarrays and expression profiling will affect clinical
practice.
British Medical Journal 319:1-2 (1999).
(Note: Current Rosetta Inpharmatics employees are shown in boldface
type.)
Stephen H. Friend, Rosetta Inpharmatics, Kirkland, WA
Abstract
In Plato's cave the participants are surrounded by shadows that
allow them to see reality by careful examination. Similarly, we
doctors at the end of the 20th century have found many indirect
tests that allow us to follow what is happening in our patients'
bodies and cells. We have learnt to cope with the fact that we cannot
find drugs unless we pull proteins from those cells and develop
inhibitors against them in the artificial context of a test tube.
Imagine now a different world in which it would be possible simultaneously
to follow many changes that were happening in cells. Imagine a doctor's
office where you could take a blood sample from a patient and get
an indication of where that patient's heart disease, kidney disease,
and depression were plotted in a matrix, allowing us, as doctors,
to see both the patient's relative state of health and any predisposition
for other conditions or disorders.
|